Shares of Shilpa Medicare Ltd were trading in the green and almost 2% higher on 12 October after the company announced that it has received European Good Manufacturing Practice (GMP) certification for its Unit 4 facility in Jadcherla, Telangana, strengthening its ability to supply pharmaceutical products to European and other international markets. 

The approval follows a successful inspection by Austria’s Agency for Health and Food Safety (AGES), conducted from 27 July to 30 July 2026.

The Jadcherla facility manufactures, tests and distributes finished pharmaceutical products, including sterile injections and non-sterile tablets and capsules. These products serve markets in Europe and other regions worldwide. 

The certification confirms that the facility meets the required European manufacturing quality standards following the regulatory inspection.

European GMP certification is an important regulatory milestone for pharmaceutical manufacturers supplying medicines to highly regulated markets. It helps establish that a manufacturing facility follows the required quality and production standards.

For Shilpa Medicare, the approval supports continued commercial supplies from Unit 4 and could help the company pursue additional business opportunities in European markets. It may also strengthen its position in contract development and manufacturing, where pharmaceutical companies work with manufacturing partners to produce medicines for different markets.

The certification comes as Shilpa Medicare continues to expand its pharmaceutical operations. In a separate development, the company received final approval from the Subject Expert Committee under India’s Central Drugs Standard Control Organisation to market OERIS, an extended-release ondansetron injection. 

The formulation is designed to help manage chemotherapy-induced nausea and vomiting for up to 120 hours after a single dose.

At 12:10 pm, the shares of Shilpa Medicare were trading 1.12% higher at Rs 1,033.10 on NSE.

Tired of guessing stocks to trade in daily?
Tradz by EquityPandit empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more. Download the Tradz by EquityPandit app today and take control of your investments!